Ramlackhansingh AF, Knight WD, Okello A, Ryan N, Turkheimer F, De Llano SR, Edison P, Douglas J, Fox NC, Brooks DJ.
Amyloid imaging in presenilin 1 mutation carriers with 11C-PiB PET.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;
Objective: In vivo investigation of amyloid distribution in pre-symptomatic and mildly affected carriers of mutated
presenilin 1 (PSEN1) using 11C-PIB PET.
Background: Mutations of the PSEN1 gene are linked to the early onset of dementia. Post mortem studies have
revealed increased amyloid deposition within the brains of these subjects. The distribution of amyloid appears to
be distinct from sporadic AD (SAD).
We aim to investigate a range of pre-symptomatic and mildly affected mutation carriers to confirm the presence
of amyloid and to identify patterns of deposition that may be distinctive to PSEN1.
Method: Seven mutation carriers (5 cognitively normal and 2 mildly affected (MMSE≥20)), 10 SAD and
10 healthy controls were studied. 11C-PiB-PET was performed on all subjects. All PET images were co-registered to
T1-weighted MRIs and regions of interest were generated using an in-house atlas. Pontine ratios were generated
of the following regions: anterior and posterior cingulated, thalamus, striatum and the frontal, temporal, parietal
occipital and cerebellar cortices.
Results: SAD subjects had significantly higher 11C-PIB binding compared to controls and PSEN1 carriers. PSEN1
carriers had significantly higher levels of 11C-PIB binding when compared to controls. Two patterns of amyloid
distribution emerged. Firstly, emphasis on the striatum occurring in E184D and intron 4 mutations and secondly,
increased cerebellar and thalamic uptake in M1461 and Y115C mutations.
Conclusions: PSEN1 gene carriers represent a distinctive group of patients. To date 185 mutations of PSEN1
gene have been published. In this study we have demonstrated the importance of investigating a range of PSEN1
mutations as different patterns of amyloid deposition have emerged. We also confirmed the presence of amyloid
in the cerebellum of these subjects supporting the use of the pons as the reference region for this cohort.